2021
DOI: 10.1111/ceo.13900
|View full text |Cite
|
Sign up to set email alerts
|

Ocular manifestations of rosacea: A clinical review

Abstract: Ocular rosacea is a chronic inflammatory condition that can occur in the absence of cutaneous features. The most common ocular features are chronic blepharoconjunctivitis with eyelid margin inflammation and meibomian gland dysfunction. Corneal complications include corneal vascularization, ulceration, scarring and, rarely, perforation. Diagnosis is largely based on clinical signs, although it is often delayed in the absence of cutaneous changes, particularly in children. It can also be associated with systemic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
36
0
7

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 38 publications
(57 citation statements)
references
References 118 publications
(214 reference statements)
1
36
0
7
Order By: Relevance
“…In general, corneal involvement occurs in about one-third of ocular rosacea cases 19 . The patients described in our case series had marked corneal findings.…”
Section: Discussionmentioning
confidence: 47%
See 3 more Smart Citations
“…In general, corneal involvement occurs in about one-third of ocular rosacea cases 19 . The patients described in our case series had marked corneal findings.…”
Section: Discussionmentioning
confidence: 47%
“…In instances when insurance does not cover cyclosporine, as seen in this case series, lifitegrast 0.5% ophthalmic solution is an acceptable substitution. Lifitegrast works similarly to cyclosporine because they both reduce T-cell–mediated ocular surface inflammation 19 …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[ 12 ] Dermatological causes include acne rosacea, which has been reported to have corneal involvement in 33% of patients. [ 13 ]…”
Section: Introductionmentioning
confidence: 99%